University of Pittsburgh

Leveraging Active Diagnostic Stewardship Interventions to Optimize the Outcomes of Patients with Bacteremia, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
화요일, 5월 14, 2024
Patient, Disease, Antimicrobial stewardship, University, Blood culture, Doctor of Pharmacy, Fungal infection, Associate, Mortality, BCID, University of Pittsburgh, Nursing

TORONTO, May 14, 2024 /PRNewswire-PRWeb/ -- Bloodstream infections are a common cause of morbidity and mortality despite advances in antimicrobial agents and sepsis management. Over the past decade, several molecular methods have been integrated into routine clinical microbiology workflows due to their ability to rapidly and simultaneously detect microorganisms and antimicrobial resistance genes from positive blood cultures.

Key Points: 
  • The impact on clinical outcomes is only realized when rapid BCID results are partnered with active stewardship interventions.
  • However, the impact on clinical outcomes is only realized when rapid BCID results are partnered with active stewardship interventions.
  • Register for this webinar today to understand how active diagnostic stewardship interventions can help optimize the outcomes of patients with bacteremia.
  • For more information, or to register for this event, visit Leveraging Active Diagnostic Stewardship Interventions to Optimize the Outcomes of Patients with Bacteremia.

Active Surfaces Secures $5.6M in Oversubscribed Pre-Seed Funding to Revolutionize Solar Technology

Retrieved on: 
월요일, 5월 13, 2024
Lendlease, Doctor of Philosophy, ACCEL, QVT, Built environment, Stanford University, University, University of Pittsburgh, MIT, Nobel Prize, MIND, VCS, Urbanization, Rice University, Innovation, Renewable energy

WOBURN, Mass., May 13, 2024 /PRNewswire/ -- Active Surfaces, an innovative flexible solar panel startup spun out from MIT, announced today it has raised $5.6 million in an oversubscribed pre-seed funding round.

Key Points: 
  • WOBURN, Mass., May 13, 2024 /PRNewswire/ -- Active Surfaces, an innovative flexible solar panel startup spun out from MIT, announced today it has raised $5.6 million in an oversubscribed pre-seed funding round.
  • Active Surfaces' lightweight, flexible solar panel technology can be integrated into virtually any surface of any size.
  • Active Surfaces is pioneering the next generation of solar technology with its lightweight, flexible solar panels that can be integrated into virtually any surface.
  • With its initial funding, Active Surfaces will scale its laboratory-fabricated 4-by-4-inch photovoltaic devices with breakthroughs in industrial roll-to-roll semiconductor printing technologies enabling mass production of thin, flexible solar materials of any size.

BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent  

Retrieved on: 
금요일, 5월 3, 2024
Science, Sorin Group, Rowan University, University, GXP, Organization, Pharmacy, Blood, Laboratory, Safety, Hospital, Supreme court, Whittier Law School, University of Pittsburgh, Bankruptcy, Johnson & Johnson, Business administration, United States district court, Supreme, MLAB, District court, Biosensors International, Wilfrid Laurier University, UCC, La Salle College, Brownstein Hyatt Farber Schreck, St. Jude Medical, University of Chicago, Boston Scientific, Management

The final compositions of the committees to the Board will be determined in the very near term.

Key Points: 
  • The final compositions of the committees to the Board will be determined in the very near term.
  • The Board is now compliant with the rules and regulations that govern the standards acceptable to major U.S.
  • Mr. Amato has hands-on executive skills at engaging and influencing key stakeholders to not only grow business but also to optimize profits.
  • Mr. Amato founded InQuest Science in March 2017 and then acquired Bridge Associates International Pharmaceutical Consulting in March 2020.

ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure

Retrieved on: 
금요일, 4월 19, 2024
Infection, ChAdOx1, HIV/AIDS, University, Bangladesh Technical Education Board, Cell, Gilead Sciences, Safety, CD4, Tissue, University of Pittsburgh, UNC, UM1, ACTG, Hook effect, Vesatolimod, Research, Toll-like receptor 7, Vaccine, University of Oxford, MVA, NIAID, University of North Carolina, Viral load, TLR7, Diagnosis, HIV, Immune system, Ageing

A5374 (Triple Immune Strategy for HIV Remission) is a multi-site, randomized, placebo-controlled trial.

Key Points: 
  • A5374 (Triple Immune Strategy for HIV Remission) is a multi-site, randomized, placebo-controlled trial.
  • After enrollment, participants will continue taking their HIV medications and will either receive a series of novel treatments or placebo.
  • Carefully monitored analytic treatment interruptions are an important part of HIV cure clinical trials.
  • ACTG is led by Dr. Currier and Joseph J. Eron, M.D., UNC (ACTG Vice-Chair).

Vimeo Appoints Philip Moyer as New Chief Executive Officer

Retrieved on: 
목요일, 4월 4, 2024
Cloud, Online, GE Aviation, Microsoft, Google Cloud, Amazon (company), Venture capital, Computer science, General Electric Company, Philip, Financial services, Business development, AI, University of Pittsburgh, University, Software, Engineering, Disclosure, Pete Musser, Alphabet Inc., Capital market, Amazon Web Services, Donnelley Financial Solutions, Creativity, S.A, Martech, Interim, Payment, Management

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Vimeo (NASDAQ: VMEO), the leading video platform for businesses, today announced the appointment of Philip Moyer as Chief Executive Officer and member of the Board of Directors, effective April 8, 2024.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Vimeo (NASDAQ: VMEO), the leading video platform for businesses, today announced the appointment of Philip Moyer as Chief Executive Officer and member of the Board of Directors, effective April 8, 2024.
  • Adam Gross, the Company’s Interim Chief Executive Officer and member of the Board, will remain on the Board after the transition.
  • “I’m thrilled to join as CEO of Vimeo, a platform that revolutionizes how millions engage with video content worldwide,” said Moyer.
  • On Monday, May 6, 2024 at 5:00pm ET, Vimeo will live stream a video conference which will include Philip to answer questions regarding its first quarter results.

Brain & Behavior Research Foundation Awards Distinguished Investigator Grants Valued at $1 Million to 10 Scientists Pursuing Innovative Mental Health Research

Retrieved on: 
목요일, 4월 4, 2024
Depression, Patient, Mitochondrion, Doctor of Science, Harvard University, Therapy, Research, Risk, Mental health, University of Pittsburgh, Brain, DSM-IV codes, Brown University, Cannabis, Memory, Safety, Spectrum, Mitophagy, Schizophrenia, Hippocampus, Bipolar disorder, Anxiety, Learning, University, Psychopathology, Cerebrospinal fluid, University of California, Distinguishing, PET, Biomarker, Hope, Baylor College of Medicine, Behavior, AMPA, Fragile X syndrome, PTSD, Pharmaceutical industry

New York, April 04, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced it is awarding Distinguished Investigator Grants valued at $1 million to 10 senior-level scientists who are conducting innovative projects in neurobiological and behavioral research.

Key Points: 
  • New York, April 04, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced it is awarding Distinguished Investigator Grants valued at $1 million to 10 senior-level scientists who are conducting innovative projects in neurobiological and behavioral research.
  • By funding transformative research focused on new ways to prevent, diagnose, and treat psychiatric disorders, our Distinguished Investigator Grants are encouraging established scientists to continue advancing our understanding of mental illness and disorders of brain and behavior,” says Jeffrey Borenstein, M.D., President and CEO of the Brain & Behavior Research Foundation.
  • The ground-breaking work of the Distinguished Investigator Grant recipients will bring hope and healing to people and families impacted by mental illness.
  • We applaud these scientists for their extraordinary dedication, innovation, and leadership.”
    Recipients of the Distinguished Investigator Grants are full professors at research institutions in the United States and abroad.

Greater Pittsburgh Festival of Books Releases Author Lineup, Opens Registration

Retrieved on: 
수요일, 4월 3, 2024
Storm, Carnegie library, Festival, HuffPost, Fordham University, Love, Acclamation, National Magazine Awards, Education Week, USA Today, The New York Times, English, Caregiver, Social justice, Barack Obama Academy, PBS, Black, Magic, Child, University, University of Pittsburgh, Teachers College, Columbia University, Perfect storm, Poetry, Diving, Carnegie Library of Pittsburgh, Catalog, Book, Death, KDKA, NPR, News Hour, Film industry

Pittsburgh, April 03, 2024 (GLOBE NEWSWIRE) -- Today, the Greater Pittsburgh Festival of Books announced registration is open for its third annual event, happening on May 11, 2024 on the campus of the Pittsburgh Theological Seminary in East Liberty.

Key Points: 
  • Pittsburgh, April 03, 2024 (GLOBE NEWSWIRE) -- Today, the Greater Pittsburgh Festival of Books announced registration is open for its third annual event, happening on May 11, 2024 on the campus of the Pittsburgh Theological Seminary in East Liberty.
  • Specially planned this year, the event will focus a portion of its programming on stories about Pittsburgh – and the greater Pittsburgh area – by hometown authors.
  • The Festival will be held from 10 a.m. to 5 p.m. on Saturday, May 11 at 616 North Highland Avenue, Pittsburgh.
  • The Festival is made possible thanks to support from sponsors including Carnegie Library of Pittsburgh, The Jack Buncher Foundation, KDKA and others.

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer

Retrieved on: 
목요일, 3월 28, 2024
Transcoding, Internal medicine, Temple University Hospital, CFO, Oncology, Patient, RNA, University, Cancer, University of Pittsburgh, Yale School of Medicine, Baylor College of Medicine, Infection, Therapy, Harvard University, Interim, Muscular dystrophy, Yale University, Pharmacia, Pharmaceutical industry

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer.

Key Points: 
  • BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer.
  • Dr. Vlock is a medical oncologist with over 25 years of industry experience and 15 years in academia, including renowned institutions Yale University, University of Pittsburgh, and Harvard University.
  • While at Pharmacia, Dr. Vlock ran the Celebrex Oncology program involving two pivotal clinical trials and over 3,500 patients.
  • Dr. Vlock initially will serve on a part-time basis through TransCode’s arrangement with BioBridges LLC, a life sciences consulting company.

Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging

Retrieved on: 
금요일, 2월 23, 2024
Methylation, Dysbiosis, Culture, Penn Center, Health, Bacteria, University, Subtypes of HIV, Life Length, Wistar Institute, Bangladesh Technical Education Board, Ileum, Infection, NIH, AIDS, Glass, Metabolomics, Nucleotide, DSM-IV codes, Biomedical Research, HIV/AIDS research, Wistar, University of Pittsburgh, DNA, Immune system, National Institutes of Health, Leiden University Medical Center, Weill Cornell Medicine, Hannum, Research, Inflammation, Blood, Ageing, Cancer, Cell biology, Microbiome, Rush University, HIV, DNA methylation, Vaccine

Dr. Abdel-Mohsen investigates what drives this rapid aging and how to create ways to slow down biological aging and improve health.

Key Points: 
  • Dr. Abdel-Mohsen investigates what drives this rapid aging and how to create ways to slow down biological aging and improve health.
  • A prime suspect in this aging puzzle is the gut microbiome and its potential leakage into the bloodstream.
  • The Abdel-Mohsen lab investigates how gut leakage can impact the immune system and lead to chronic inflammation, which may accelerate aging.
  • Their analysis revealed a significant connection between disrupted gut microbiomes, increased intestinal permeability (leaky gut), and faster biological aging.

InScribe Alongside A Guest Panel Receives Student Support and Success Best-in-Track Award at OLC Innovate

Retrieved on: 
목요일, 3월 7, 2024
New Mexico Highlands University, Teaching, University, Success, University of Illinois Urbana-Champaign, Provost, University of Pittsburgh, Entrepreneurship, Compulsory figures, Fort Hays, Faculty, Student, Fort Hays State University, Knowledge, Gies College of Business, Education

DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- InScribe Education is delighted to share our achievement alongside a distinguished guest panel in receiving the Best-in-Track Award for Student Support and Success at the OLC Innovate 2023 conference. This accolade celebrates the most impactful presentations, as chosen by conference attendees.

Key Points: 
  • The Best-in-Track Award for Student Support and Success at OLC Innovate 2023 was awarded to InScribe for their timely session on fostering a sense of belonging for online learners.
  • DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- InScribe Education is delighted to share our achievement alongside a distinguished guest panel in receiving the Best-in-Track Award for Student Support and Success at the OLC Innovate 2023 conference .
  • InScribe warmly congratulates our panelists and appreciates their vital contributions to this session.
  • On behalf of the entire panel, InScribe extends our gratitude to the OLC for recognizing our hard work, innovation, and dedication to improving the online learning experience.